SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-056026
Filing Date
2022-11-07
Accepted
2022-11-07 19:25:05
Documents
2
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1609
2 POA DOCUMENT poa.txt EX-24 4020
  Complete submission text file 0001209191-22-056026.txt   7014
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD RD. SOUTH HAMILTON Z4 L8P 0A6
Business Address
Bobilev Dmitri (Reporting) CIK: 0001952201 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 221366860